Normal
0
false
false
false
EN-US
X-NONE
X-NONE
MicrosoftInternetExplorer4
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-qformat:yes;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin-top:0in;
mso-para-margin-right:0in;
mso-para-margin-bottom:6.0pt;
mso-para-margin-left:0in;
line-height:110%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"Times New Roman";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;}
As you may have noticed, the ITN website has undergone some pretty major
changes. We hope you enjoy the new look and will find the new site easier to
navigate and as informative as our previous versions.
Our website has gone through several iterations since the ITN was founded in 1999. Prior to this redesign, the last revision took place in May 2002, when
the ITN was still relatively young and was conducting only a handful of clinical trials. Today the ITN has a growing portfolio of over 20 clinical
trials, a full-time staff of over 80, over a dozen validated core facilities
and research collaborations with numerous industry, academic and government
partners. The new design reflects the dynamic nature of the ITN, highlighting
some of our investigators and others who have come together under the
banner of the ITN.
Choose your flavor
When you enter from www.immunetolerance.org
for the first time, you will be given the choice between the "Research
Professionals" pages or the "General Public" pages. Choose one, and the next
time you visit, you'll automatically be taken to those pages (however, if you
clear the cookies from your browser, you may be asked to choose again on your
next visit). If you change your mind mid-visit, you can always switch using the
links at the bottom of each page.
News where you want to read it
Over the coming months, we'll be updating the site regularly with news about
new and existing ITN trials, research developments and feature stories about ITN
people and research. You now have the option of subscribing to ITN news using
RSS. Click on the RSS icon (like the one at right) in your browser, or copy the
following URL into your RSS reader to subscribe - http://www.immunetolerance.org/professionals/feed.
We hope you like our new look! As always, we appreciate your feedback.
Please send all comments to webmaster@immunetolerance.org.
